Multipurpose research reactor providing radiopharmaceutical
Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial
Showing 81 - 100 of 347 results
Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial
ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.
In partnership with the Australian Museum as part of National Science Week explore the 2020 hackathon theme of Deep Blue: Innovation for the future of our oceans
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
Meeting of minds about potential next-generation cancer treatment for Australians
On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.
State- of-the-art microdosimeters used in research
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
Molten Salt Reactors (MSRs) are nuclear reactors that use a fluid fuel in the form of very hot fluoride or chloride salt rather than the solid fuel used in most reactors. Since the fuel salt is liquid, it can be both the fuel to produce heat and the coolant to transport the heat to a power plant.
ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.
Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.
The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.
Sample environments, Data analysis, SpICE and SICS
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,